![John Orloff](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Orloff
Inga fler pågående positioner
Förmögenhet: - $ per 2026-06-30
Profil
John J.
Orloff is currently a Non-Executive Director at Zenas BioPharma (USA) LLC, an Independent Director at Zenas BioPharma, Inc. since 2022, and a Venture Partner at Agent Capital LLC since 2021.
Former positions include Senior Director at Merck Research Laboratories Massachusetts LLC, Director at Novelion Therapeutics, Inc. from 2017 to 2019, Non-Executive Director at BenevolentAI Ltd. from 2021 to 2024, Independent Non-Executive Director at BenevolentAI SA from 2021 to 2024, Executive VP, Head-Research & Development at Alexion Pharmaceuticals, Inc. from 2017 to 2021, Executive Vice President & Head-Research at Aegerion Pharmaceuticals, Inc., Chief Scientific Officer, EVP, Global Head-R&D at Baxalta, Inc. from 2015 to 2016, Vice President, Global Head-Research & Development at Baxter BioScience Corp.
from 2014 to 2015, and Chief Medical Officer & Senior Vice President at Novartis Pharma AG.
Education includes an undergraduate degree from Dartmouth College in 1979 and a doctorate from the University of Vermont College of Medicine in 1983.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
-.--% | 2026-06-15 | 0 ( -.--% ) | - $ | 2026-06-30 |
Aktiva positioner av John Orloff
| Företag | Position | Start |
|---|---|---|
Agent Capital LLC
 Agent Capital LLC Investment ManagersFinance Agent Capital invests in companies located in the United States. The firm targets companies operating in the fields of therapeutics sectors and industries. It provides financing for seed, early, late stage, crossover and PIPE stage requirements. The firm acts as a lead investor and also makes co-investments. | Privat kapitalinvesterare | 2021-10-01 |
Zenas Pharma, Inc.
 Zenas Pharma, Inc. BiotechnologyHealth Technology Develops and markets immunology based therapies for patients | Direktör/Styrelseledamot | - |
Tidigare kända positioner av John Orloff
| Företag | Position | Slut |
|---|---|---|
| BENEVOLENTAI S.A. | Direktör/Styrelseledamot | 2024-10-16 |
BenevolentAI Ltd.
 BenevolentAI Ltd. Packaged SoftwareTechnology Services Operates as a AI-enabled drug discovery company | Direktör/Styrelseledamot | 2024-10-01 |
| ALEXION PHARMACEUTICALS, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2021-07-21 |
| NOVELION THERAPEUTICS INC. | Teknisk/Vetenskaplig/F&U Direktör | 2017-07-01 |
| BAXALTA INC | Teknisk/Vetenskaplig/F&U Direktör | 2016-06-01 |
John Orloffs utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
68
Första gradens relationer
13
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 13 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders | Health Technology |
Aegerion Pharmaceuticals, Inc.
 Aegerion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes therapies for hyperlipidemia and metabolic diseases | Health Technology |
Baxalta, Inc.
 Baxalta, Inc. Pharmaceuticals: MajorHealth Technology Engages in research, development and manufacture of therapies and biopharmaceutical products | Health Technology |
Dartmouth College
 Dartmouth College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Baxter BioScience Corp.
 Baxter BioScience Corp. BiotechnologyHealth Technology Provides biopharmaceutical and vaccines services | Health Technology |
Merck Research Laboratories Massachusetts LLC
 Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Health Technology |
Novartis Pharma AG
 Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
University of Vermont College of Medicine
 University of Vermont College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novelion Therapeutics, Inc.
 Novelion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets rare disease products, metreleptin and lomitapide | Health Technology |
BenevolentAI Ltd.
BenevolentAI Ltd. Packaged SoftwareTechnology Services Operates as a AI-enabled drug discovery company | Technology Services |
Agent Capital LLC
Agent Capital LLC Investment ManagersFinance Agent Capital invests in companies located in the United States. The firm targets companies operating in the fields of therapeutics sectors and industries. It provides financing for seed, early, late stage, crossover and PIPE stage requirements. The firm acts as a lead investor and also makes co-investments. | Finance |
BenevolentAI SA
 BenevolentAI SA Packaged SoftwareTechnology Services Develops AI drug discovery platform to accelerate biopharma drug discovery | Technology Services |
Zenas Pharma, Inc.
Zenas Pharma, Inc. BiotechnologyHealth Technology Develops and markets immunology based therapies for patients | Health Technology |
